Atomwise has 6 close competitors: Halda Therapeutics, Ecovativa Design, NantOmics.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
AtomwiseEcovativa DesignNantOmicsInsitroFormation BioAI-powered drug discovery platform using physics-based simulations and machine learning to identify novel drug candidates for pharmaceutical companies.
Atomwise competes with 6 companies here: Halda Therapeutics, Ecovativa Design, NantOmics, Insitro, Formation Bio, Retro Biosciences.
Atomwise was last valued at $320M . That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
No. Atomwise is a private company; its shares do not trade on a public exchange.
The last valuation is $320M.
Lead investors for each round are in the funding timeline.
The closest biotechnology / ai drug discovery peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
